PMC:7199903 / 206-575
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T2 | 4-11 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T3 | 152-157 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T4 | 215-223 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T5 | 345-358 | Body_part | denotes | glycopeptides | http://purl.org/sig/ont/fma/fma82784 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T6 | 27-36 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 74-77 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T3 | 78-80 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
T4 | 152-157 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T5 | 162-167 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T2 | 4-11 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T3 | 345-358 | Chemical | denotes | glycopeptides | http://purl.obolibrary.org/obo/CHEBI_24396 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 27-36 | http://purl.obolibrary.org/obo/IDO_0000586 | denotes | infection |
T3 | 95-100 | http://purl.obolibrary.org/obo/BFO_0000029 | denotes | sites |
T4 | 112-117 | http://purl.obolibrary.org/obo/BFO_0000029 | denotes | sites |
T5 | 152-157 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cells |
T6 | 162-167 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T7 | 172-178 | http://purl.obolibrary.org/obo/IDO_0000586 | denotes | infect |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T30 | 4-11 | NN | denotes | protein |
T31 | 12-16 | WDT | denotes | that |
T32 | 17-26 | VBZ | denotes | initiates |
T33 | 27-36 | NN | denotes | infection |
T34 | 38-42 | DT | denotes | Each |
T35 | 43-51 | NN | denotes | protomer |
T36 | 52-54 | IN | denotes | in |
T37 | 55-58 | DT | denotes | the |
T38 | 59-67 | JJ | denotes | trimeric |
T39 | 68-73 | NN | denotes | spike |
T40 | 74-77 | VBZ | denotes | has |
T41 | 78-80 | CD | denotes | 22 |
T42 | 81-94 | NN | denotes | glycosylation |
T43 | 95-100 | NNS | denotes | sites |
T44 | 102-105 | WRB | denotes | How |
T45 | 106-111 | DT | denotes | these |
T46 | 112-117 | NNS | denotes | sites |
T47 | 118-121 | VBP | denotes | are |
T48 | 122-134 | VBN | denotes | glycosylated |
T49 | 135-138 | MD | denotes | may |
T50 | 139-145 | VB | denotes | affect |
T51 | 146-151 | WDT | denotes | which |
T52 | 152-157 | NNS | denotes | cells |
T53 | 158-161 | DT | denotes | the |
T54 | 162-167 | NN | denotes | virus |
T55 | 168-171 | MD | denotes | can |
T56 | 172-178 | VB | denotes | infect |
T57 | 179-182 | CC | denotes | and |
T58 | 183-188 | MD | denotes | could |
T59 | 189-195 | VB | denotes | shield |
T60 | 196-200 | DT | denotes | some |
T61 | 201-209 | NNS | denotes | epitopes |
T62 | 210-214 | IN | denotes | from |
T63 | 215-223 | NN | denotes | antibody |
T64 | 224-238 | NN | denotes | neutralization |
T65 | 240-248 | NNP | denotes | Watanabe |
T66 | 249-251 | FW | denotes | et |
T67 | 252-255 | FW | denotes | al. |
T68 | 256-265 | VBN | denotes | expressed |
T69 | 266-269 | CC | denotes | and |
T70 | 270-278 | VBN | denotes | purified |
T71 | 279-290 | JJ | denotes | recombinant |
T72 | 291-303 | VBN | denotes | glycosylated |
T73 | 304-309 | NN | denotes | spike |
T74 | 310-317 | NNS | denotes | trimers |
T75 | 317-318 | -COMMA- | denotes | , |
T76 | 319-330 | VBD | denotes | proteolysed |
T77 | 331-335 | PRP | denotes | them |
T78 | 336-338 | TO | denotes | to |
T79 | 339-344 | VB | denotes | yield |
T80 | 345-358 | NNS | denotes | glycopeptides |
T81 | 359-369 | VBG | denotes | containing |
R29 | T30 | T31 | arg1Of | protein,that |
R30 | T30 | T32 | arg1Of | protein,initiates |
R31 | T33 | T32 | arg2Of | infection,initiates |
R32 | T35 | T34 | arg1Of | protomer,Each |
R33 | T35 | T36 | arg1Of | protomer,in |
R34 | T39 | T36 | arg2Of | spike,in |
R35 | T39 | T37 | arg1Of | spike,the |
R36 | T39 | T38 | arg1Of | spike,trimeric |
R37 | T35 | T40 | arg1Of | protomer,has |
R38 | T43 | T40 | arg2Of | sites,has |
R39 | T43 | T41 | arg1Of | sites,22 |
R40 | T43 | T42 | arg1Of | sites,glycosylation |
R41 | T48 | T44 | arg1Of | glycosylated,How |
R42 | T46 | T45 | arg1Of | sites,these |
R43 | T46 | T47 | arg1Of | sites,are |
R44 | T48 | T47 | arg2Of | glycosylated,are |
R45 | T46 | T48 | arg2Of | sites,glycosylated |
R46 | T44 | T49 | arg1Of | How,may |
R47 | T50 | T49 | arg2Of | affect,may |
R48 | T44 | T50 | arg1Of | How,affect |
R49 | T51 | T50 | arg2Of | which,affect |
R50 | T52 | T51 | arg1Of | cells,which |
R51 | T54 | T53 | arg1Of | virus,the |
R52 | T54 | T55 | arg1Of | virus,can |
R53 | T56 | T55 | arg2Of | infect,can |
R54 | T54 | T56 | arg1Of | virus,infect |
R55 | T52 | T56 | arg2Of | cells,infect |
R56 | T50 | T57 | arg1Of | affect,and |
R57 | T59 | T57 | arg2Of | shield,and |
R58 | T44 | T58 | arg1Of | How,could |
R59 | T59 | T58 | arg2Of | shield,could |
R60 | T44 | T59 | arg1Of | How,shield |
R61 | T61 | T59 | arg2Of | epitopes,shield |
R62 | T61 | T60 | arg1Of | epitopes,some |
R63 | T61 | T62 | arg1Of | epitopes,from |
R64 | T64 | T62 | arg2Of | neutralization,from |
R65 | T64 | T63 | arg1Of | neutralization,antibody |
R66 | T74 | T65 | arg1Of | trimers,Watanabe |
R67 | T67 | T66 | arg1Of | al.,et |
R68 | T65 | T67 | arg1Of | Watanabe,al. |
R69 | T67 | T68 | arg2Of | al.,expressed |
R70 | T68 | T69 | arg1Of | expressed,and |
R71 | T70 | T69 | arg2Of | purified,and |
R72 | T67 | T70 | arg2Of | al.,purified |
R73 | T74 | T71 | arg1Of | trimers,recombinant |
R74 | T74 | T72 | arg2Of | trimers,glycosylated |
R75 | T74 | T73 | arg1Of | trimers,spike |
R77 | T74 | T76 | arg1Of | trimers,proteolysed |
R78 | T77 | T76 | arg2Of | them,proteolysed |
R79 | T79 | T76 | arg3Of | yield,proteolysed |
R80 | T79 | T78 | arg1Of | yield,to |
R81 | T77 | T79 | arg1Of | them,yield |
R82 | T80 | T79 | arg2Of | glycopeptides,yield |
R83 | T80 | T81 | arg1Of | glycopeptides,containing |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T2 | 4-11 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T3 | 152-157 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T4 | 215-223 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T5 | 345-358 | Body_part | denotes | glycopeptides | http://purl.org/sig/ont/fma/fma82784 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T2 | 4-11 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T3 | 345-358 | Chemical | denotes | glycopeptides | http://purl.obolibrary.org/obo/CHEBI_24396 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 38-101 | Sentence | denotes | Each protomer in the trimeric spike has 22 glycosylation sites. |
T5 | 102-239 | Sentence | denotes | How these sites are glycosylated may affect which cells the virus can infect and could shield some epitopes from antibody neutralization. |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T5 | 27-36 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
18 | 304-309 | Gene | denotes | spike | Gene:43740568 |
21 | 68-73 | Gene | denotes | spike | Gene:43740568 |
22 | 345-358 | Chemical | denotes | glycopeptides | MESH:D006020 |
25 | 27-36 | Disease | denotes | infection | MESH:D007239 |
LitCovid-sample-PD-GO-BP-0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 81-94 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
LitCovid-sample-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 81-94 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 81-94 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 38-101 | Sentence | denotes | Each protomer in the trimeric spike has 22 glycosylation sites. |
T5 | 102-239 | Sentence | denotes | How these sites are glycosylated may affect which cells the virus can infect and could shield some epitopes from antibody neutralization. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
18 | 304-309 | Gene | denotes | spike | Gene:43740568 |
21 | 68-73 | Gene | denotes | spike | Gene:43740568 |
22 | 345-358 | Chemical | denotes | glycopeptides | MESH:D006020 |
25 | 27-36 | Disease | denotes | infection | MESH:D007239 |